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In adults, angiosarcoma is the most common type of
cardiac sarcoma but is still rare and metastatic tumors to the
heart occur far more often.2 Presentation is usually late, and
most are unresectable.3 Treatment has been pursued in an ad
hoc manner with surgery, chemotherapy, and radiotherapy,
all playing roles without the benefit of clinical trials.4
A recent case report from Japan noted a durable re-
sponse of 12 months using radiation with concomitant and
then maintenance docetaxel. By using the same, we observed
a partial response followed by progression-free survival for
16 months. The literature suggests survival in the range of 4
to 5 months for patients with extensive unresectable disease.5
The patient was dependent on chest tubes to drain
pleural effusions for his last several months. The pleural
effusions were not clearly related to his tumor. We were not
able to ascertain to what degree his final symptoms were
related to radiation-related damage to the lungs, heart, or
pericardium. It is possible that chronic pericardial changes
from radiation may have contributed, but radiation-induced
pericardial changes would be obscured on computed tomog-
raphy by pericardial tumor involvement and pleural effusion.
By using chemoradiotherapy, we were able to obtain a doc-
umented partial response and a prolonged course of stable
disease for 16 months including a return to work for 11
months. This regimen deserves further investigation.
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Erratum
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH: Erratum
In the article that appeared on page 459 of the March issue, Figure 2 included an identifying number in the top right corner which should have been
removed. The corrected figure appears below. This error has been noted in the online version of the article, which is available at www.jto.org.
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FIGURE 3. Magnetic resonance imaging on follow-up in
February 2009, 4 months after completing radiation therapy.
A decrease in tumor size is noted, 5.2 cm  4.2 cm.
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